✦ LIBER ✦

Combination chemotherapy of metastatic breast cancer. A randomized trial comparing the use of adriamycin to that of vinblastine

✍ Scribed by Dr. W. R. Bezwoda; N. G. De Moor; D. Derman; M. Lange; R. Saner; R. Dando

Publisher: John Wiley and Sons
Year: 1979
Tongue: English
Weight: 470 KB
Volume: 44
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(197908)44:2<392::aid-cncr2820440204>3.0.co;2-d

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Combination chemotherapy of metastatic b

Combination chemotherapy of metastatic breast cancer with vincristine, adriamycin and prednisolone

✍ J. A. Russell; J. W. Baker; P. J. Dady; H. T. Ford; J. C. Gazet; J. A. McKinna; 📂 Article 📅 1978 🏛 John Wiley and Sons 🌐 English ⚖ 336 KB 👁 2 views

Chemotherapy of advanced breast cancer:

Chemotherapy of advanced breast cancer: A randomized trial of vincristine, adriamycin, and cyclophosphamide (VAC) versus cyclophosphamide, methotrexate, 5-fluorouracil, and prednisone (CMFP)

✍ J. Carmo-Pereira; F. Oliveira Costa; Elvira Henriques 📂 Article 📅 1981 🏛 John Wiley and Sons 🌐 English ⚖ 402 KB 👁 2 views

Treatment of metastatic breast cancer in

Treatment of metastatic breast cancer in estrogen receptor positive patients a randomized trial comparing tamoxifen alone versus tamoxifen plus CMF

✍ W. R. Bezwoda; D. Derman; N. G. De Moor; M. Lange; J. Levin 📂 Article 📅 1982 🏛 John Wiley and Sons 🌐 English ⚖ 421 KB 👁 1 views

Methotrexate, vinblastine, doxorubicin,

Methotrexate, vinblastine, doxorubicin, and cisplatin in metastatic breast cancer. A phase II trial of the hoosier oncology group

✍ Bruce J. Roth; George W. Sledge Jr; Stephen D. Williams; Steven C. Meyer; Rafat 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 490 KB 👁 2 views

Forty-six eligible patients with metastatic breast cancer (MBC) were treated with a combination of methotrexate, vinblastine, doxorubicin, and cisplatin (M-VAC) as first-line chemotherapy. Of 44 patients evaluable for response, 28 (64%) had an objective response, including seven (16%) who had a comp

A randomized trial of tamoxifen alone or

A randomized trial of tamoxifen alone or combined with octreotide in the treatment of women with metastatic breast carcinoma

✍ James N. Ingle; Vera J. Suman; Carl G. Kardinal; James E. Krook; James A. Mailli 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 110 KB 👁 2 views

## BACKGROUND. Tamoxifen (TAM) is generally considered the hormonal agent of choice for postmenopausal women with hormone receptor positive breast carcinoma. The somatostatin analogues, including octreotide, have demonstrated inhibition of breast carcinoma cell lines and multiple endocrinologic act

Cyclophosphamide (NSC 26271) versus the

Cyclophosphamide (NSC 26271) versus the combination of adriamycin (NSC 123127), 5-fluorouracil (NSC 19893), and cyclophosphamide in the treatment of metastatic prostatic cancer. A randomized trial

✍ Rowan T. Chlebowski; Robert Hestorff; Leonard Sardoff; John Weiner; Joseph R. Ba 📂 Article 📅 1978 🏛 John Wiley and Sons 🌐 English ⚖ 460 KB 👁 1 views